BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Avalo to Present at the 2023 Jefferies Healthcare Conference

  Avalo Therapeutics, Inc. announced that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 11:00 a.m. ET at the Marriott Marquis in New York, NY.

  June 1, 2023

   · 

  3 min read
• Lone Star Bio

  Plus Therapeutics Provides Company Update Today

  Plus Therapeutics, Inc. announced that Marc Hedrick, M.D., President and Chief Executive Officer, will provide a comprehensive update of the Company’s recent activity and progress to date during a presentation at the 2023 Virtual June Investor Summit on Thursday, June 1, 2023, at 2:00 p.m. ET.

  June 1, 2023

   · 

  4 min read
• Drug Development

  Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

  Monopar Therapeutics Inc. today announced an update from its currently enrolling multi-center open-label Phase 1b clinical trial of camsirubicin in patients with advanced soft tissue sarcoma (ASTS).

  June 1, 2023

   · 

  5 min read
• Bio NC

  Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference - June 1, 2023

  Milestone Pharmaceuticals Inc. today announced that members of its management team will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 8:30 a.m. ET.

  June 1, 2023

   · 

  1 min read
• Seegene Obtains IVDR Certification for 30 Diagnostic Assays

  Seegene Inc. announced today that it has obtained the European Union’s In Vitro Diagnostic Medical Device Regulation (IVDR) certification for 30 diagnostic assays.

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  Abilita Bio Changes Name to Abilita Therapeutics and Appoints Joel Edwards as Chief Business Officer

  Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to Abilita Therapeutics.

  June 1, 2023

   · 

  3 min read
• Pharm Country

  Bristol Myers Squibb to Participate in Upcoming Investor Conferences

  Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the following investor conferences in June 2023.

  June 1, 2023

   · 

  1 min read
• Business

  Switch Therapeutics Announces Formation of Scientific Advisory Board

  Switch Therapeutics today announced the formation of its Scientific Advisory Board.

  June 1, 2023

   · 

  4 min read
• Business

  Bausch + Lomb Announces Key Leadership Changes

  Bausch + Lomb Corporation announced a reshaping of its executive leadership team, including the elevation of all business unit heads.

  June 1, 2023

   · 

  3 min read
• ADC Therapeutics to Participate in the Jefferies Healthcare Conference

  ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th at 8:30 a.m. EDT.

  June 1, 2023

   · 

  4 min read